Biogen’s new global headquarters at 75 Broadway has received a major industry honor, earning CoStar’s 2026 Impact Award for Lease of the Year in Boston. The recognition highlights the significance of the landmark lease within MIT’s Kendall Common development and its impact on the broader Cambridge life sciences market. The lease, executed with BioMed Realty and MIT Investment Management Co., brings together Biogen’s research, technical operations, and commercial teams into a single, purpose‑built facility totaling approximately 580,000 square feet.
For nearly five decades, Biogen has been a defining presence in Kendall Square and a key contributor to Cambridge’s position as one of the world’s leading life sciences ecosystems. This new headquarters reinforces that legacy at a pivotal moment for the sector, marking a major recommitment to the innovation district.
As the general contractor, John Moriarty & Associates is proud to help deliver a state‑of‑the‑art building designed to support Biogen’s next chapter. The project incorporates advanced conservation strategies, high‑efficiency systems, and sustainable, lab‑ready design — reflecting the industry’s growing emphasis on facilities that balance innovation with environmental responsibility.
Congratulations to Biogen, BioMed Realty, MITIMCo, Elkus Manfredi Architects, and all partners involved in this transformative project.
Read the full CoStar article here.
